Brussels, 18/01/2002 (Agence Europe) - Ahead of the publication next week of its strategy for biotechnology, the European Commission published a report on 14 January assessing the implications for basic genetic engineering research of failure to publish, or late publication of, papers on subjects which could be patentable.
Research institutes, universities and small biotech companies, which are major contributors to innovation in life sciences, may wish to file patent applications but at...